BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8893973)

  • 1. Remnant-like particles (RLP) from NIDDM patients with apolipoprotein E3/3 phenotype stimulate cholesteryl ester synthesis in human monocyte-derived macrophages.
    Saito M; Eto M; Okada M; Iwashima Y; Makino I
    Artery; 1996; 22(3):155-63. PubMed ID: 8893973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remnant-like lipoprotein particles in type 2 diabetic patients with apolipoprotein E3/3 and apolipoprotein E2 genotypes.
    Saito M; Eto M; Kaku K
    Metabolism; 2002 Aug; 51(8):964-9. PubMed ID: 12145767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triglyceride-rich lipoproteins from apolipoprotein E3/2 subjects with hypertriglyceridemia enhance cholesteryl ester synthesis in human macrophages.
    Saito M; Eto M; Makino I
    Atherosclerosis; 1997 Feb; 129(1):73-7. PubMed ID: 9069520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired blood rheology by remnant-like lipoprotein particles: studies in patients with fatty liver disease.
    Kurihara T; Deguchi S; Kato J; Furakawa M; Tsuchiya M; Akimoto M; Ishiguro H; Hashimoto H; Niimi A; Maeda A; Shigemoto M; Yamashita K; Kawakami A; Umemura K; Nakashima M; Nakano T; Saniabadi AR
    Clin Hemorheol Microcirc; 2001; 24(4):217-25. PubMed ID: 11564910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship of serum lipoprotein lipase mass with fasting serum apolipoprotein B-48 and remnant-like particle triglycerides in type 2 diabetic patients.
    Kobayashi J; Nakajima K; Nohara A; Kawashiri M; Yagi K; Inazu A; Koizumi J; Yamagishi M; Mabuchi H
    Horm Metab Res; 2007 Aug; 39(8):612-6. PubMed ID: 17712727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein B gene variants are involved in the determination of blood glucose and lipid levels in patients with non-insulin dependent diabetes mellitus.
    Duman BS; Oztürk M; Yilmazer S; Cağatay P; Hatemi H
    Cell Biochem Funct; 2006; 24(3):261-7. PubMed ID: 16634094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotype-dependent differences in apolipoprotein E metabolism and in cholesterol homeostasis in human monocyte-derived macrophages.
    Cullen P; Cignarella A; Brennhausen B; Mohr S; Assmann G; von Eckardstein A
    J Clin Invest; 1998 Apr; 101(8):1670-7. PubMed ID: 9541497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of apolipoprotein E gene polymorphism with ischemic stroke involving large-vessel disease and its relation to serum lipid levels.
    Saidi S; Slamia LB; Ammou SB; Mahjoub T; Almawi WY
    J Stroke Cerebrovasc Dis; 2007; 16(4):160-6. PubMed ID: 17689412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E genotypes and metabolic risk factors for coronary heart disease in middle-aged women.
    Cubrilo-Turek M; Stavljenić-Rukavina A; Sertić J; Zrinski R; Turek S; Grgac G; Ljubojević N
    Coll Antropol; 1998 Jun; 22(1):149-55. PubMed ID: 10097431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesteryl ester transfer protein promotes the formation of cholesterol-rich remnant like lipoprotein particles in human plasma.
    Okamoto H; Miyai A; Sasase T; Furukawa N; Matsushita M; Nakano T; Nakajima K
    Clin Chim Acta; 2007 Jan; 375(1-2):92-8. PubMed ID: 16859664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycation of low-density lipoprotein results in the time-dependent accumulation of cholesteryl esters and apolipoprotein B-100 protein in primary human monocyte-derived macrophages.
    Brown BE; Rashid I; van Reyk DM; Davies MJ
    FEBS J; 2007 Mar; 274(6):1530-41. PubMed ID: 17480204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E polymorphism in type 2 diabetic patients of Talca, Chile.
    Leiva E; Mujica V; Orrego R; Prieto M; Arredondo M
    Diabetes Res Clin Pract; 2005 Jun; 68(3):244-9. PubMed ID: 15936467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does pravastatin increase chylomicron remnant catabolism in postmenopausal women with type 2 diabetes mellitus?
    Ng TW; Watts GF; Stuckey BG; Ching HL; Chan DC; Uchida Y; Sakai N; Yamashita S; Martins IJ; Redgrave TG; Barrett PH
    Clin Endocrinol (Oxf); 2005 Dec; 63(6):650-6. PubMed ID: 16343099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remnant-like particle cholesterol levels in Korean patients with coronary artery disease and non-insulin dependent diabetes mellitus.
    Song J; Park H; Hong SH; Lee HK; Park YB; Kim JQ
    Clin Chem Lab Med; 2000 May; 38(5):427-32. PubMed ID: 10952226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between apolipoprotein E genetic polymorphism and the development of diabetic nephropathy in type 2 diabetic patients.
    Kwon MK; Rhee SY; Chon S; Oh S; Woo JT; Kim SW; Kim JW; Kim YS; Jeong KH; Lee SH; Lee TW; Ihm CG
    Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S228-32. PubMed ID: 17624465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concerted actions of cholesteryl ester transfer protein and phospholipid transfer protein in type 2 diabetes: effects of apolipoproteins.
    Dallinga-Thie GM; Dullaart RP; van Tol A
    Curr Opin Lipidol; 2007 Jun; 18(3):251-7. PubMed ID: 17495597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The relationship of Apo E2 and renal insufficiency lipid levels in NIDDM].
    Xiang G; Xia B; He Y
    Zhonghua Yi Xue Za Zhi; 1999 May; 79(5):339-41. PubMed ID: 11715472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid synthesis in macrophages derived from the human cell line THP-1: modulation of the effects of native and oxidized chylomicron-remnant-like particles by oestrogen.
    Napolitano M; Batt KV; Avella M; Bravo E; Botham KM
    Clin Sci (Lond); 2001 Oct; 101(4):403-13. PubMed ID: 11566078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of nephropathy on the composition of apolipoprotein-containing particles in NIDDM.
    Nagai T; Tomizawa T; Nakajima K; Uehara Y; Mori M
    J Atheroscler Thromb; 1998; 5(2):54-9. PubMed ID: 10855558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo.
    Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.